INS 2026 PHILADELPHIA
Continuing Education (CE) Program
CE Program Overview
INS continuing education (CE) sessions are designed to provide a practical review of current research as well as information on clinical and technological advances in specific areas of content relevant to neuropsychology and the cognitive neurosciences. All INS continuing education sessions are geared for advanced level instructional activity.
Up to 21.5 credit hours are available for this live, in-person program.
The International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content.
The International Neuropsychological Society is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists (#PSY-0154).
TWO CE OPTIONS
Optional CE
Every plenary and most invited symposia are available for optional credit. These sessions are open to all attendees.
To obtain the CE, you must pay a separate registration fee and attend the entire session (a volunteer proctor will distribute attendance slips at the door).
CE Workshops
Workshops are only open to pre-registered attendees. These are closed sessions—your badge will be checked at the door.
You must pre-register to enter the session. You must submit an attendance slip to receive credit.
2-Hour Workshops
When do 2-hour workshops occur?
All two-hour workshops occur on Wednesday, February 4th. Click on the sessions below for specific dates and times, or to register or bookmark workshops.
To receive CE, you must:
2-HOUR WORKSHOPS:
Wednesday February 4 | 8:45-10:45 AM
Workshop 1
PET Brain Imaging for Diagnosis and Treatment in Neurodegenerative Disease
2 Hours CE Credit | Introductory Level
This session will be divided into two parts. First will be a presentation on brain PET for neurodegenerative disease. This will cover the following topics: 1) Patient journey for a brain PET study; 2) How a PET images is made and what they show; 3) Clinically-available radiopharmaceuticals used for brain PET for neurodegenerative disease; 4) Basics of interpretation of fluorodeoxyglucose (FDG), amyloid, and tau PET. The second part will be a mock consensus diagnostic conference, simulating the clinical process of physician presenting and discussing history, physical exam, laboratory, and imaging data for new patients with cognitive decline. Attendees will see the interaction of Neurology, Neuropsychology, and Neuroimaging during this component.
Workshop 01
SNMMI Series, Part 1: PET brain imaging for diagnosis and treatment in neurodegenerative disease
Ilya Nasrallah, MD, PhD
Dawn Mechanic-Hamilton, PhD
Kyra O'Brien, MD, MSHP
Wednesday February 4 | 8:45-10:45 AM
Workshop 01
PET Brain Imaging for Diagnosis and Treatment in Neurodegenerative Disease
2 Hours CE Credit | Introductory Level
Learning Objectives
- Learn how brain PET imaging is performed
- Learn the indications for and basics of interpretation of brain PET for neurodegenerative disease
- Understand how brain PET is used in the pathway for diagnosis of patients with cognitive decline
Workshop 02
Critical Research on Mild Traumatic Brain Injury for Clinical and Forensic Neuropsychological Examinations
David Schretlen, PhD
Wednesday February 4 | 8:45-10:45 AM
Workshop 02
Critical Research on Mild Traumatic Brain Injury for Clinical and Forensic Neuropsychological Examinations
2 Hours CE Credit | Intermediate Level
Learning Objectives
- Attendees will learn how much or how little mild TBI affects overall cognitive performance during the acute vs. post-acute phases of recovery, what factors that moderate this, and how these effect sizes compare to cognitive morbidity observed in other health conditions.
- Attendees will be able to describe specific TBI research methods that strengthen or weaken the likely validity of a study’s results, thereby building each listener’s confidence and ability to evaluate the credibility of reported scientific findings.
- Attendees will be able to describe the main findings of over a dozen critically important studies that inform our knowledge of risk factors for sustaining TBI, the natural history of mTBI recovery, the nonspecific nature of many symptoms attributed to mTBI, and obvious indices of mTBI recovery outside of clinical neuropsychological testing.
Workshop 03
The Use of Neuropsychological Formulation in Rehabilitation of People with Brain Injury: Its Role in Guiding Rehabilitation and Understanding Complex and Puzzling Cases
Jill Winegardner, PhD
Christian Salas, PhD
Wednesday February 4 | 8:45-10:45 AM
Workshop 03
The Use of Neuropsychological Formulation in Rehabilitation of People with Brain Injury: Its Role in Guiding Rehabilitation and Understanding Complex and Puzzling Cases
2 Hours CE Credit | Intermediate Level
Learning Objectives
- Attendees will be able to describe the use of neuropsychological formulation in neuropsychological rehabilitation.
- Attendees will be able to describe the difference between a standard neuropsychological report and a neuropsychological formulation.
- Attendees will be able to create formulations in their own practices after this workshop
Workshop 04
SNMMI Series, Part 2: Advanced PET Brain Imaging: Instrumentation, Quantification Strategies, and Cutting-Edge Applications
Jacob Dubroff, MD, PhD
Elizabeth Li, PhD
Wednesday February 4 | 12:15-2:15 PM
Workshop 04
Advanced PET Brain Imaging: Instrumentation, Quantification Strategies, and Cutting-Edge Applications
2 Hours CE Credit | Advanced Level
Learning Objectives
- Appreciate the evolution of PET instrumentation in capturing more precise and accurate measurements.
- Learn how different quantification approaches are applied to PET data.
- Understand how PET imaging can elucidate neuropathological mechanism in various neuropsychiatric diseases including epilepsy and addiction.
Wednesday February 4 | 8:45-10:45 AM
Workshop 1
PET Brain Imaging for Diagnosis and Treatment in Neurodegenerative Disease
2 Hours CE Credit | Introductory Level
This session will be divided into two parts. First will be a presentation on brain PET for neurodegenerative disease. This will cover the following topics: 1) Patient journey for a brain PET study; 2) How a PET images is made and what they show; 3) Clinically-available radiopharmaceuticals used for brain PET for neurodegenerative disease; 4) Basics of interpretation of fluorodeoxyglucose (FDG), amyloid, and tau PET. The second part will be a mock consensus diagnostic conference, simulating the clinical process of physician presenting and discussing history, physical exam, laboratory, and imaging data for new patients with cognitive decline. Attendees will see the interaction of Neurology, Neuropsychology, and Neuroimaging during this component.
Workshop 05
Demystifying AI—Risks and Opportunities that Support Assessment and Treatment Resources for Persons with Neurodevelopmental and Neurocognitive Impairments
David Brown, M.Engl., PhD
Wednesday February 4 | 12:15-2:15 PM
Workshop 05
Demystifying AI—Risks and Opportunities that Support Assessment and Treatment Resources for Persons with Neurodevelopmental and Neurocognitive Impairments
2 Hours CE Credit | Intermediate Level
Learning Objectives
- Assess the distinction between inherently explainable and post hoc approaches to designing AI-based systems and why this distinction is especially significant when designing AI for people with neurodevelopmental and neurocognitive impairments.
- Describe how XAI’s capabilities are being explored across a range of applications for persons with neurodevelopmental and neurocognitive Impairments from predicting and de-escalating emotional dysregulation, reducing social anxiety, to assessing cognitive changes over time when combined with virtual reality, brain informatics and biofeedback.
- Discuss the challenges of actively pursuing inclusive, ethical, and bias-aware AI and why these are important for justice and wellbeing for persons with neurodevelopmental and neurocognitive impairments.
Workshop 06
The Sense of Smell and its Relevance for Neuropsychology
Jonas Olofsson, PhD
Wednesday February 4 | 12:15-2:15 PM
Workshop 06
The Sense of Smell and its Relevance for Neuropsychology
2 Hours CE Credit | Intermediate Level
Learning Objectives
- Describe the anatomical and physiological principles of the human olfactory system.
- Explain how different neuropsychological conditions affect olfactory functions differently.
- Apply olfactory interventions to rehabilitate sensory or cognitive abilities.
1.5-Hour Breakfast Workshops
When do breakfast workshops occur?
All 1.5-hour workshops are scheduled the mornings of Thursday through Saturday, February 5th-7th. Click on the sessions below for specific dates and times, or to register or bookmark workshops.
To receive CE, you must:
1.5-HOUR WORKSHOPS:
Workshop 07
Beyond “90% specificity”: Statistical Advances in Interpreting Performance Validity Tests
Robert Spencer, PhD
Thursday February 5 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 07
Beyond “90% specificity”: Statistical Advances in Interpreting Performance Validity Tests
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Attendees will be able to articulate the differences between sensitivity, specificity, positive predictive power, and negative predictive power.
- Attendees will be able to discuss at least two limitations of using cut-off scores when assessing for performance validity.
- Attendees will be able to describe at least one alternative method to employing a 90% specificity standard when assessing performance validity.
Workshop 08
An Update on Blood-based Biomarkers for Alzheimer's Disease and Related Dementias
Nicholas Kanaan, PhD
Thursday February 5 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 08
An Update on Blood-based Biomarkers for Alzheimer's Disease and Related Dementias
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Explain core blood-biomarker assay platforms and identify leading and emerging plasma biomarkers for dementia.
- Evaluate the current evidence for research and early translational use of blood-based biomarkers and recognize their limitations.
- Apply these concepts to research and clinical decision-support scenarios by understanding the available biomarker assays and interpreting biomarker results.
Workshop 09
Neuromodulation for Major Depression: Clinical Progress and Cognitive Outcomes
Jean-Phillipe Miron, MD, PhD
Friday February 6 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 09
Neuromodulation for Major Depression: Clinical Progress and Cognitive Outcomes
1.5 Hours CE Credit | Advanced Level
Learning Objectives
- Describe the neurobiological mechanisms, clinical efficacy, and cognitive outcomes associated with major neuromodulation approaches for treatment-resistant depression, including TMS, tDCS, MST, and VNS.
- Differentiate the cognitive effects of each modality, recognizing domains where improvements, stability, or trade-offs are most likely to occur.
- Apply knowledge of neuromodulation mechanisms and cognitive outcomes to evaluate clinical cases of treatment-resistant depression and guide treatment selection or research design.
Workshop 10
Mind the Gap: Bridging Culture and Cognition in Neuropsychological Assessment
Aparna Dutt, PhD
Tedd Judd, PhD
Jonathan Evans, Bsc (Hons), PhD
Friday February 6 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 10 - Cultural SIG
Mind the Gap: Bridging Culture and Cognition in Neuropsychological Assessment
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Know how to find information pertinent to the neuropsychological evaluation of specific language and cultural populations.
- Know how to develop the clinical skills needed for rapport and for confident, accurate interviews, testing, and clinical reasoning with patients from varied languages and cultures.
- Be able to use the neuropsychological application of the International Test Commission’s Test Adaptation and Translation Guidelines to evaluate the appropriateness of translated tests for specific individuals.
Workshop 11
Identifying and Supporting Children and Adolescents with Executive Dysfunction
Daryaneh Badaly, PhD
Saturday February 7 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 11
Identifying and Supporting Children and Adolescents with Executive Dysfunction
1.5 Hours CE Credit | Introductory Level
Learning Objectives
- Describe different theoretical models, developmental trajectories, and brain correlates of executive functioning.
- Identify and differentiate approaches to the assessment of executive functioning in children and adolescents.
- Provide recommendations for executive functioning skills training for children and adolescents as well as psychoeducation of everyday strategies for executive dysfunction.
Workshop 12
Cannabis and Cognition in Aging and Risk for Dementia
Andreana Benitez, PhD
Saturday February 7 | 7:00-8:50 AM
Breakfast 7:00-7:15 AM | Session begins promptly at 7:20 AM
Workshop 12
Identifying and Supporting Children and Adolescents with Executive Dysfunction
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Describe the epidemiology and cannabis use practices among US older adults to contextualize the impact of this growing trend on clinical care and research
- Discuss the current evidence base on the impact of cannabis use on cognitive aging and risk for dementia
- Identify sex differences in the outcomes of cannabis use to better tailor clinical decision-making and hypothesis generation for research with older adults
